GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea

Go back to GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
AGENUS (NASDAQ: AGEN) Delayed: 7.43 -0.81 (9.83%)
Previous Close $8.24    52 Week High $7.49 
Open $8.14    52 Week Low $2.61 
Day High $8.18    P/E N/A 
Day Low $7.42    EPS $-1.10 
Volume 1,207,565       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.54 -1.35 (2.71%)
Previous Close $49.89    52 Week High $45.58 
Open $49.00    52 Week Low $37.82 
Day High $49.23    P/E N/A 
Day Low $48.54    EPS $0.00 
Volume 3,062,278